Meet the Team
Founder & CEO
Stanford PhD, Co-inventor, Decade of experience with mRNA for therapeutic applications. Thesis title: Telomere extension to extend human healthspan.
Founder & COO
Stanford PhD, Decade of experience in genetics and epigenetics of cellular reprogramming.
Director, Translational Development and Project Management
Molecular and Cellular Biology, Functional Genomics
Stanford trained PhD with deep experience in both research and production environments.
Chief Medical Officer
MBBS MRCP FRACP MD FQA, Internationally-recognized thoracic transplant physician and translational clinician researcher, Clinical Professor at U. of Queensland, Executive Director of Research at Australia’s largest health service, and heads one of the world’s largest clinical trials programs in lung fibrosis, KOL on role of short telomeres in lung fibrosis.
Director, Scientific Research
MD, PhD. Over 20 years’ experience in biomedical and translational research focusing on liver and intestinal diseases at Stanford University.
Life Science Research Associate II
BSc in Cell and Molecular Biology.
Director of Finance and Administration
Stanford AB in Cultural Anthropology, 30+ years of F&A experience supporting research excellence at Stanford School of Medicine.
Chemistry, Manufacturing, and Controls (CMC)
PhD, 11 years as Director of Manufacturing at Arbutus precursor Tekmira, Biologics CMC head at Nitto Denko, multiple other companies.
Former Director at Arcturus Therapeutics in mRNA LNP development.
Pharmacologist and toxicologist, over 100 INDs
Led Pirfenidone approval, entrepreneur, fibrotic disease expert.
Founder & Advisor
Co-inventor, Professor at Stanford University, discovered that short telomeres underlie the fatal etiology of multiple monogenic diseases.
>100 INDs as the founder of the first biologics translational department at City of Hope, Los Angeles.
Christine Kim Garcia
Chief of Pulmonary, Allergy and Critical Care Medicine and Professor of Medicine at Columbia University Irving Medical Center, KOL on role of short telomeres in pulmonary fibrosis.
Professor and Chair Pulmonary Medicine at Cedars Sinai, Leading Clinician-Researcher in IPF.
VP Preclinical Development
PHD, MBA, Led two startups from bench to clinic and aquisition, respectively.